As of 2025-12-21, the Relative Valuation of Novocure Ltd (NVCR) is (73.57) USD. This relative valuation is based on P/E multiples. With the latest stock price at 12.84 USD, the upside of Novocure Ltd based on Relative Valuation is -673.0%.
The range of the Relative Valuation is (55.18) - (92.05) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 32.8x - 60.9x | 47.4x |
| Forward P/E multiples | 34.8x - 58.0x | 45.3x |
| Fair Price | (55.18) - (92.05) | (73.57) |
| Upside | -529.7% - -816.9% | -673.0% |
| Date | P/E |
| 2025-12-18 | -7.92 |
| 2025-12-17 | -7.77 |
| 2025-12-16 | -8.15 |
| 2025-12-15 | -8.18 |
| 2025-12-12 | -8.40 |
| 2025-12-11 | -8.61 |
| 2025-12-10 | -8.33 |
| 2025-12-09 | -8.01 |
| 2025-12-08 | -7.60 |
| 2025-12-05 | -7.63 |
| 2025-12-04 | -7.41 |
| 2025-12-03 | -7.44 |
| 2025-12-02 | -6.88 |
| 2025-12-01 | -7.36 |
| 2025-11-28 | -8.07 |
| 2025-11-26 | -8.04 |
| 2025-11-25 | -7.97 |
| 2025-11-24 | -7.90 |
| 2025-11-21 | -7.53 |
| 2025-11-20 | -7.22 |
| 2025-11-19 | -7.22 |
| 2025-11-18 | -7.22 |
| 2025-11-17 | -7.10 |
| 2025-11-14 | -7.14 |
| 2025-11-13 | -7.17 |
| 2025-11-12 | -7.16 |
| 2025-11-11 | -7.48 |
| 2025-11-10 | -7.10 |
| 2025-11-07 | -6.88 |
| 2025-11-06 | -7.10 |
| 2025-11-05 | -7.32 |
| 2025-11-04 | -7.56 |
| 2025-11-03 | -7.71 |
| 2025-10-31 | -8.07 |
| 2025-10-30 | -8.08 |
| 2025-10-29 | -8.50 |
| 2025-10-28 | -8.43 |
| 2025-10-27 | -8.56 |
| 2025-10-24 | -8.67 |
| 2025-10-23 | -8.77 |
| 2025-10-22 | -8.74 |
| 2025-10-21 | -8.91 |
| 2025-10-20 | -9.13 |
| 2025-10-17 | -8.69 |
| 2025-10-16 | -8.84 |
| 2025-10-15 | -8.94 |
| 2025-10-14 | -8.30 |
| 2025-10-13 | -8.35 |
| 2025-10-10 | -8.50 |
| 2025-10-09 | -9.03 |